DANIELLE EMERY: Open Payments
NPI 1174294862 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,448 in 107 payments from 25 companies in 2025. Trend: 2023 $3,423 · 2024 $2,669 · 2025 $2,448
Food & beverage: $2,448
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 11 | $293 |
| Novo Nordisk Inc | 12 | $288 |
| Xeris Pharmaceuticals, Inc. | 11 | $210 |
| Tandem Diabetes Care, Inc. | 7 | $191 |
| Ascendis Pharma Endocrinology Inc | 7 | $167 |
| Almatica Pharma LLC | 10 | $158 |
| Dexcom, Inc. | 3 | $135 |
| BETA BIONICS, INC. | 6 | $133 |
| Novartis Pharmaceuticals Corporation | 7 | $124 |
| Madrigal Pharmaceuticals | 4 | $115 |
Products named: TZIELD, t:slim X2 Insulin Pump with Control-IQ, Yorvipath, Wegovy, TERIPARATIDE, GVOKE HYPOPEN, iLet Bionic Pancreas, REZDIFFRA.
Industry payments across FL — which companies pay providers there.
